| Title |
Metformin monotherapy for type 2 diabetes mellitus
|
|---|---|
| Published by |
John Wiley & Sons, Ltd, July 2005
|
| DOI | 10.1002/14651858.cd002966.pub3 |
| Pubmed ID | |
| Authors |
Saenz, Antonio, Fernandez-Esteban, Inmaculada, Mataix, Angel, Ausejo Segura, Monica, Roqué i Figuls, Marta, Moher, David |
| Abstract |
Metformin is an anti-hyperglycaemic agent used for the treatment of type 2 diabetes mellitus. Type 2 diabetes may present long-term complications: micro- (retinopathy, nephropathy and neuropathy) and macrovascular (stroke, myocardial infarction and peripheral vascular disease). Two meta-analyses have been published before, although only secondary outcomes were assessed. |
Twitter Demographics
The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 217 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 3 | 1% |
| Brazil | 3 | 1% |
| Italy | 2 | <1% |
| United States | 2 | <1% |
| Denmark | 1 | <1% |
| Ireland | 1 | <1% |
| Unknown | 205 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 36 | 17% |
| Student > Bachelor | 34 | 16% |
| Researcher | 28 | 13% |
| Student > Ph. D. Student | 24 | 11% |
| Other | 18 | 8% |
| Other | 41 | 19% |
| Unknown | 36 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 115 | 53% |
| Agricultural and Biological Sciences | 17 | 8% |
| Nursing and Health Professions | 12 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 4% |
| Biochemistry, Genetics and Molecular Biology | 4 | 2% |
| Other | 15 | 7% |
| Unknown | 45 | 21% |